Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol-Reference-Cited by-同舟云学术

Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol

Published:2012-12-18 Issue:11 Volume:62 Page:1634-1641
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Reiberger Thomas,Ulbrich Gregor,Ferlitsch Arnulf,Payer Berit Anna,Schwabl Philipp,Pinter Matthias,Heinisch Birgit B,Trauner Michael,Kramer Ludwig,Peck-Radosavljevic Markus,

Publisher

BMJ

Subject

Gastroenterology

Reference27 articles.

1. Complications of cirrhotic. I. Portal hypertension;Bosch;J Hepatol,2000

2. Von Willebrand factor as new non-invasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhotic;Ferlitsch;Hepatology,2012

3. Portal pressure, presence of gastroesophageal varices and variceal bleeding;Garcia-Tsao;Hepatology,1985

4. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage;Groszmann;Gastroenterology,1990

5. Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding;Cerqueira;Eur J Gastroenterol Hepatol,2012

Cited by 269 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic immune regulation and sex disparities;Nature Reviews Gastroenterology & Hepatology;2024-09-05

2. Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab;Digestive and Liver Disease;2024-09

3. Pharmacologic Treatment of Portal Hypertension;Clinics in Liver Disease;2024-08

4. Non-Selective Beta-Blockers in Patients with Cirrhosis: Current Evidence and Controversy;Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management;2024-06-17

5. Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis;PLOS ONE;2024-06-13